#therapeutics — Friday, September 18, 2026 (3 items)
| 0 | ℹ |
Ubiquitin receptor-mediated, ubiquitin-independent targeted protein degradation via 26S proteasomes.
(science.org)
|
Science Advances 2026-09-18 | #protein degradation #proteolysis #proteasome #ubiquitin #therapeutics | |
| 0 | ℹ |
Mechanistic insights into VSIR-mediated AXL regulation and gastric cancer proliferation.
(linkinghub.elsevier.com)
|
iScience 2026-09-18 | #cancer #transcriptomics #signaling #therapeutics #immunoregulation | |
| 0 | ℹ |
Functional diversity of natural human IFNB1 variants in innate immunity.
(science.org)
|
Science Advances 2026-09-18 | #immunity #variants #interferon #infection #therapeutics |